Sandostatin LAR depot 20 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26FQU3X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,214
Award facts
- Contract value 100% obligated
- $42,214.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a $42,214.48 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits. This firm fixed-price contract represents a non-set-aside competitive award with an ultimate completion date of January 14, 2026. The awardee, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. The contract is a child order under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen's role as a critical vendor in the federal pharmaceutical supply chain reflects its extensive portfolio of delivery orders with the Defense Logistics Agency, covering medications across multiple therapeutic domains including specialty treatments, vaccines, and generic pharmaceuticals. The Sandostatin LAR Depot award specifically addresses medical supply needs for military treatment facilities and other government healthcare institutions served through DLA's procurement operations. This transaction exemplifies the company's ongoing capability to fulfill competitive federal medical procurement requirements for essential pharmaceutical commodities supporting Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQU3X?
SPE2DR26FQU3X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FQU3X worth?
The government has obligated $42,214 on SPE2DR26FQU3X.
Is contract SPE2DR26FQU3X an order under another contract?
Yes. SPE2DR26FQU3X is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQU3X competed?
The extent of competition for SPE2DR26FQU3X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award